Recent investigations have focused on the convergence of GLP-1|GIP|GCGR agonist therapies and DA neurotransmission. While GLP stimulators are commonly employed for treating type 2 diabetes mellitus, their potential consequences on reinforcement circuits, specifically mediated by DA systems, are attracting substantial focus. This report details a… Read More